课题基金 / 基金详情

Training Component

Training Component
培训部分
批准号：
9114678
负责人：
Charles E McCulloch
金额：
$9.21万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/9114678
关键词：
Brain Vascular MalformationClinicalClinical ResearchClinical SciencesDevelopmentFacultyGoalsHome environmentInstitutesInstitutionLeadLettersLocationPositioning AttributePostdoctoral FellowQualifyingRare DiseasesRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResourcesTimeTrainingTraining ProgramsTranslational ResearchWagescareerclinical predictorsmultidisciplinarynext generationprograms

项目摘要

项目成果

Charles E McCulloch的其他基金

相似基金

相关文献

中文摘要
翻译
培训部分的总体目标是培养成功的，独立的，临床和翻译研究人员，他们专注于罕见疾病的研究，并能够领导一个多学科团队。学者的培训将被整合到家庭机构的临床和翻译培训中（例如，临床和转化科学研究所（Clinical and Translational Sciences Institute at UCSF）我们将支持高级博士后或临床研究员（他们将在明年成为独立研究员），初级教师或希望发展或重新关注罕见疾病临床研究的既定研究人员。 目的：招募和培养高素质的罕见病研究人员。
英文摘要
The overall goal of the training component is the development of successful, independent, clinical and translational investigators who focus on the study of rare diseases and are able to lead a multidisciplinary team. The training of the scholar will be integrated into the clinical and translational training of the home institution (e.g., the Clinical and Translational Sciences Institute at UCSF). We will support advanced postdoctoral or clinical fellows (who will be independent investigators within the next year), junior faculty, or established investigators who wish to develop or refocus their careers on clinical research in rare diseases. Aim: To recruit and train highly qualified investigators in rare disease research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving statistical inference when interest focuses on the identification of extreme random effects in clustered data
Improving statistical inference when interest focuses on the identification of extreme random effects in clustered data
Career Enhancement Core
Career Enhancement Core
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data